October 31, 2018 — Medical imaging software company Mirada Medical showcased its DLCExpert at the recent American Society for Radiation Oncology (ASTRO) 2018 annual meeting, oct. 21-24 in San Antonio, Texas. The product, which has received U.S. Food and Drug Administration (FDA) 510(k) clearance, is the world’s first artificial intelligence (AI)-powered autocontouring solution. The software is already in use in multiple academic medical centers worldwide.
DLCExpert automatically generates contours that users often find indistinguishable from those drawn by clinical experts, according to Mirada Medical. The software has been shown to bring quality and consistency to the task of contouring critical structures for radiation treatment planning.
DLCExpert received CE Marking for the European market earlier this year. Medical institutions across Europe are currently commissioning the product to exploit the significant benefits that AI brings to their contouring workflow.
Andre Dekker, professor of clinical data science, Department of Radiation Oncology at the Maastro Clinic in Maastricht, The Netherlands, stated, “The contours generated by DLCExpert are the closest to clinically acceptable contours we’ve seen from any autocontouring system we have evaluated. For some organs, our clinicians found it very hard to distinguish between their own contours and those that were automatically generated”.
U.S. regulatory clearance for DLCExpert was granted as part of the FDA 510(k) for Workflow Box 2.0, Mirada’s Zero-Click automation platform. DLCExpert is available as an option, along with five additional Zero-Click workflows, including multi-modal autocontouring, routing of data and support for the integration of custom applications.
See an example of this technology in the VIDEO: Artificial Intelligence Automatic Contouring and Segmentation For Radiotherapy.
For more information: www.mirada-medical.com
May 16, 2024 
